Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 
Nataliya V. Uboha, MD, PhD close
Nataliya V. Uboha, MD, PhD

New Patients

Need help selecting a primary care doctor? Contact the Welcome Center for personal assistance.

For Referring Physicians

How to refer a patient

Nataliya V. Uboha, MD, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Uboha is an assistant professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, Madison, WI. She specializes in gastrointestinal (GI) malignancies. 


Specialties

Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
Richland Hospital
(608) 647-6321 | | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
University Hospital
(608) 263-7502 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital
Veterans Hospital - Wm. S. Middleton Memorial

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Internal Medicine
Medical Oncology
Fellowship Smilow Cancer Hospital at Yale-New Haven Hospital, New Haven, CT
Residency Yale New Haven Hospital, New Haven, CT
Medical School Yale University School of Medicine, New Haven, CT

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Her research interests are dedicated to the development of biomarker based early phase clinical trials for patients with GI cancer. Dr. Uboha has received numerous funding awards for her research and is actively engaged in developing clinical trials for patients with GI malignancies. Her background and PhD in molecular biology allows for in-depth understanding of molecular mechanisms underlying tumorigenesis and drug development.


PubMed Articles
Shah MH Goldner WS Halfdanarson TR Bergsland E Berlin JD Halperin D Chan J Kulke MH Benson AB 3rd Blaszkowsky LS Eads J Engstrom PF Fanta P Giordano T He J Heslin MJ Kalemkerian GP Kandeel F Khan SA Kidwai WZ Kunz PL Kuvshinoff BW 2nd Lieu C Pillarisetty VG Saltz L Sosa JA Strosberg JR Sussman CA Trikalinos NA Uboha NA Whisenant J Wong T Yao JC Burns JL Ogba N Zuccarino-Catania G NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. J Natl Compr Canc Netw . 2018 Jun;16(6):693-702
[PubMed ID: 29891520]
Lubner SJ Uboha NV Deming DA Primary and acquired resistance to biologic therapies in gastrointestinal cancers. J Gastrointest Oncol . 2017 Jun;8(3):499-512
[PubMed ID: 28736637]
Uboha N Hochster HS TAS-102: a novel antimetabolite for the 21st century. Future Oncol . 2016 Jan;12(2):153-63
[PubMed ID: 26616466]
Deming D Uboha N Zafar SY Rosenberg S Bassetti M Glasgow S Borden EC Lubner S Adjuvant Chemotherapy for Stage II Rectal Cancer. Semin Oncol . 2015 Dec;42(6):e99-107
[PubMed ID: 26615141]
Uboha NV Flajolet M Nairn AC Picciotto MR A calcium- and calmodulin-dependent kinase Ialpha/microtubule affinity regulating kinase 2 signaling cascade mediates calcium-dependent neurite outgrowth. J Neurosci . 2007 Apr 18;27(16):4413-23
[PubMed ID: 17442826]
Stedman DR Uboha NV Stedman TT Nairn AC Picciotto MR Cytoplasmic localization of calcium/calmodulin-dependent protein kinase I-alpha depends on a nuclear export signal in its regulatory domain. FEBS Lett . 2004 May 21;566(1-3):275-80
[PubMed ID: 15147908]